Clinical Trial Update: Study Evaluating the Effect of Lecozotan SR on the QTc Interval [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effect of Lecozotan SR on the QTc interval in individuals with Alzheimer disease and healthy volunteers, which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecozotan SR (lecozotan SR)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease, Healthy | Phase 1 | Status: COMPLETED